Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Mona Al‐Rasheed"'
Autor:
Omar H. Metwally, Alaa Rahhal, Raghad A. Elsherif, Ahmed M. Elshoeibi, Mohamed Elhadary, Amgad M. Elshoeibi, Ahmed Badr, Basel Elsayed, Mona Al- Rasheed, Awni Alshurafa, Mohamed A. Yassin
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 54, Iss , Pp 101493- (2024)
This review aimed to assess bleeding risks and explore management options in atrial fibrillation (AF) patients with immune thrombocytopenia (ITP), aiming to formulate an optimal therapeutic approach for improved patient prognosis. Employing MeSH term
Externí odkaz:
https://doaj.org/article/e5f4d10b1708404e8099ffce8a81f3e5
Autor:
Mohamed A. Yassin, Mona Al-Rasheed, Murtadha Al-Khaboori, Mahmoud Marashi, Hani Osman, Yasser Wali, Salam Al Kindi, Faisal Alsayegh, Drew Provan
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
IntroductionThrombopoietin-receptor agonist (TPO-RAs) currently represent the state of art for treating immune thrombocytopenia. Their different molecular structures contribute to the difference in their pharmacodynamics and pharmacokinetics. This na
Externí odkaz:
https://doaj.org/article/4f6a087b656b418f86cf0903c7502c43
Publikováno v:
eJHaem, Vol 2, Iss 3, Pp 534-536 (2021)
Abstract Acquired thrombotic thrombocytopenic purpura is characterized by the microvascular aggregation of platelets and microangiopathic hemolytic anemia causing ischemia of multiple organs including the brain mainly and less likely the kidney and t
Externí odkaz:
https://doaj.org/article/983cb334562f43f48cb0a834d39f495c
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022)
Externí odkaz:
https://doaj.org/article/660d82e4ced14dd2a62da7451a6dc028
Autor:
Amgad M. Elshoeibi, Khaled Ferih, Ahmed Adel Elsabagh, Basel Elsayed, Mohamed Elhadary, Mahmoud Marashi, Yasser Wali, Mona Al-Rasheed, Murtadha Al-Khabori, Hani Osman, Mohamed Yassin
Publikováno v:
Diagnostics, Vol 13, Iss 6, p 1060 (2023)
Thrombocytopenia is a medical condition where blood platelet count drops very low. This drop in platelet count can be attributed to many causes including medication, sepsis, viral infections, and autoimmunity. Clinically, the presence of thrombocytop
Externí odkaz:
https://doaj.org/article/ef148983c7f3495fa7090f14db3113bb
Publikováno v:
International Journal of Hematology
Background Data regarding thrombosis after COVID-19 vaccination are scarce. Methods Clinical and laboratory data were collected from all patients who developed thrombosis within 4 weeks of receiving the Pfizer or Oxford/AstraZeneca vaccine. None had
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45a3138969a835ee421e85483acfbfc1
https://doi.org/10.1007/s12185-021-03285-6
https://doi.org/10.1007/s12185-021-03285-6
Publikováno v:
Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 34(1)
Some reports have discussed the development of a new entity called vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination. In this case series, we are describing four patients who have developed lupus anticoagulant-associated v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b14bb6dd5058c179c14b090987c3807
https://pubmed.ncbi.nlm.nih.gov/35946452
https://pubmed.ncbi.nlm.nih.gov/35946452
Autor:
Faisal Alsayegh, Mona Al-Rasheed, Ali Al-Muhaini, Shaker A. Mousa, Ekhlas Al-Humoud, Mona Al-Ostaz
Publikováno v:
Cardiovascular Therapeutics
The aim of this study is to assess the practice of heparin administration in real-life situations. This study was conducted at the coronary care unit (CCU) in one of the busiest hospitals in Kuwait; with special attention to the rate of heparin resis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff3267218d3921fab3a03a68db2f6f82
https://doi.org/10.1111/j.1755-5922.2009.00076.x
https://doi.org/10.1111/j.1755-5922.2009.00076.x
Publikováno v:
Annals of hematology. 88(3)
The objective of this study was to evaluate the efficacy and safety of rituximab in the treatment of patients with idiopathic thrombocytopenic purpura (ITP). A prospective study was performed at Mubarak Al-Kabeer University Hospital involving the use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff324ed56a88658815352458fda58912
https://pubmed.ncbi.nlm.nih.gov/18704420
https://pubmed.ncbi.nlm.nih.gov/18704420
Autor:
Elshoeibi, Amgad M.1 (AUTHOR) ae1902917@qu.edu.qa, Ferih, Khaled1 (AUTHOR), Elsabagh, Ahmed Adel1 (AUTHOR), Elsayed, Basel1 (AUTHOR), Elhadary, Mohamed1 (AUTHOR), Marashi, Mahmoud2 (AUTHOR), Wali, Yasser3 (AUTHOR), Al-Rasheed, Mona4 (AUTHOR), Al-Khabori, Murtadha5 (AUTHOR), Osman, Hani6 (AUTHOR), Yassin, Mohamed7 (AUTHOR) ae1902917@qu.edu.qa
Publikováno v:
Diagnostics (2075-4418). Mar2023, Vol. 13 Issue 6, p1060. 19p.